Canonical Amplifications and CDKN2A/B Loss Refine IDH1/2-mutant Astrocytoma Prognosis

CDKN2A 星形细胞瘤 突变体 IDH1 癌症研究 生物 遗传学 胶质瘤 基因
作者
Hia S. Ghosh,Ruchit V. Patel,Elizabeth B. Claus,L. Nicolas Gonzalez Castro,Patrick Y. Wen,Keith L. Ligon,David M. Meredith,Wenya Linda Bi
出处
期刊:Neuro-oncology [Oxford University Press]
被引量:1
标识
DOI:10.1093/neuonc/noae258
摘要

Abstract Background Molecular features have been incorporated alongside histologic criteria to improve glioma diagnostics and prognostication. CDKN2A/B homozygous-loss associates with worse survival in IDH1/2-mutant astrocytomas (IDHmut-astrocytomas), the presence of which denotes a grade 4 tumor independent of histologic features. However, no molecular features distinguish survival amongst histologically defined grade 2 and 3 IDHmut-astrocytomas. Methods We assembled a cohort of patients ≥19 years old diagnosed with an IDHmut-astrocytoma between 1989 and 2020 from public datasets and several academic medical centers. Multivariate modeling and unbiased clustering were used to stratify risk. Results We identified 998 IDHmut-astrocytoma patients (41.5% female; 85.6% white). Tumor grade, CDKN2A/B loss, and/or ≥1 focal amplification were associated with reduced survival. Grade 2/3 patients with intact CDKN2A/B and no focal amplifications survived the longest (OS 205.7 months). Survival for grade 2/3 cases with either CDKN2A/B hemizygous-loss or focal amplifications (80.4, 88.7 months respectively) did not differ significantly from grade 4 cases with intact CDKN2A/B and no amplifications (91.5 months, P = .93). Grade 4 patients with either hemizygous or homozygous loss of CDKN2A/B had the shortest survival (OS 31.9, 32.5 months respectively), followed by grade 4 cases with intact CDKN2A/B and focal gene amplifications (OS 55.9 months). Integrating CDKN2A/B status and amplifications alongside histopathologic grade refined overall survival prediction. Unbiased clustering revealed 9 distinct molecular profiles, with differential survival. IDHmut-astrocytomas with any CDKN2A/B loss clustered together, regardless of grade, and exhibited the poorest outcomes. Conclusions Combining CDKN2A/B hemizygous-loss and focal gene amplifications reveals a group of IDHmut-astrocytoma patients with an intermediate prognosis, refining IDHmut-astrocytoma classification.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YY发布了新的文献求助10
1秒前
mannich发布了新的文献求助10
1秒前
CodeCraft应助包容的代荷采纳,获得10
1秒前
1秒前
1秒前
2秒前
慕青应助Dan采纳,获得10
2秒前
3秒前
唐清羽应助汤圆软软软采纳,获得10
3秒前
3秒前
3秒前
唐清羽应助汤圆软软软采纳,获得10
3秒前
研友_VZG7GZ应助汤圆软软软采纳,获得10
3秒前
3秒前
研友_VZG7GZ应助汤圆软软软采纳,获得10
4秒前
orixero应助汤圆软软软采纳,获得10
4秒前
唐清羽应助汤圆软软软采纳,获得10
4秒前
唐清羽应助汤圆软软软采纳,获得10
4秒前
5秒前
苏休夫发布了新的文献求助10
5秒前
5秒前
ray发布了新的文献求助10
6秒前
漫步云端完成签到,获得积分10
6秒前
123完成签到,获得积分10
6秒前
葱姜蒜辣椒香菜我全要完成签到,获得积分10
7秒前
旷野发布了新的文献求助10
7秒前
7秒前
小回忆完成签到,获得积分10
7秒前
8秒前
GAP发布了新的文献求助10
9秒前
10秒前
11秒前
11秒前
斯文败类应助hzwhz采纳,获得10
11秒前
远志发布了新的文献求助10
11秒前
安详的白枫完成签到,获得积分10
11秒前
灵巧的雪卉完成签到,获得积分10
12秒前
aaaa应助锤子简历采纳,获得20
13秒前
kk发布了新的文献求助10
13秒前
光亮的元容完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The anomeric effect 1000
Principles of town planning: translating concepts to applications 1000
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7731509
求助须知:如何正确求助?哪些是违规求助? 9282580
关于积分的说明 20152745
捐赠科研通 7308922
什么是DOI,文献DOI怎么找? 3303709
关于科研通互助平台的介绍 2456546
邀请新用户注册赠送积分活动 2312444